Insider Selling: Select Medical Holdings Co. (NYSE:SEM) Director Sells 32,000 Shares of Stock

Select Medical Holdings Co. (NYSE:SEM) Director Marilyn B. Tavenner sold 32,000 shares of the firm’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total value of $674,880.00. Following the completion of the transaction, the director now owns 22,000 shares in the company, valued at approximately $463,980. This represents a 59.26 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Select Medical Trading Up 3.7 %

NYSE SEM traded up $0.76 during trading on Friday, reaching $21.11. 1,201,404 shares of the stock traded hands, compared to its average volume of 634,308. Select Medical Holdings Co. has a fifty-two week low of $20.00 and a fifty-two week high of $40.98. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. The firm has a market cap of $2.73 billion, a price-to-earnings ratio of 9.86, a price-to-earnings-growth ratio of 0.91 and a beta of 1.42. The stock’s 50-day moving average price is $34.11 and its 200 day moving average price is $34.71.

Select Medical (NYSE:SEM) last announced its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.07. The company had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.74 billion. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The firm’s revenue was up 5.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.46 EPS. Analysts predict that Select Medical Holdings Co. will post 2.16 EPS for the current year.

Select Medical Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Wednesday, November 13th were issued a $0.125 dividend. This represents a $0.50 annualized dividend and a dividend yield of 2.37%. The ex-dividend date of this dividend was Wednesday, November 13th. Select Medical’s dividend payout ratio (DPR) is presently 23.36%.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the stock. Royal Bank of Canada raised their target price on shares of Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. Bank of America started coverage on shares of Select Medical in a report on Tuesday, August 20th. They set a “buy” rating and a $42.00 target price for the company. Benchmark downgraded Select Medical from a “buy” rating to a “hold” rating in a research note on Monday. Finally, StockNews.com cut Select Medical from a “buy” rating to a “hold” rating in a research note on Thursday, November 21st. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $40.75.

Institutional Investors Weigh In On Select Medical

A number of hedge funds and other institutional investors have recently bought and sold shares of SEM. Kingsview Wealth Management LLC acquired a new position in shares of Select Medical during the 3rd quarter worth about $1,927,000. Tidal Investments LLC acquired a new stake in shares of Select Medical in the first quarter valued at about $467,000. Dynamic Technology Lab Private Ltd acquired a new stake in shares of Select Medical in the third quarter valued at about $1,592,000. Hood River Capital Management LLC acquired a new stake in shares of Select Medical in the second quarter valued at about $14,819,000. Finally, Comerica Bank increased its position in shares of Select Medical by 30.0% in the first quarter. Comerica Bank now owns 68,485 shares of the health services provider’s stock valued at $2,065,000 after acquiring an additional 15,824 shares during the last quarter. Institutional investors and hedge funds own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.